Inventor
ROIZMAN BERNARD
US39 patents
⚠️ This page may combine multiple inventors who share the name “ROIZMAN BERNARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARCH DEV CORP
22 patentsUS5328688AJul 12, 1994
Recombinant herpes simplex viruses vaccines and methods
ARCH DEV CORP160 citations99
US5288641AFeb 22, 1994
Herpes Simplex virus as a vector
ARCH DEV CORP227 citations99
US5599691AFeb 4, 1997
Herpes simplex virus as a vector
ARCH DEV CORP45 citations96
US5876923AMar 2, 1999
Herpes simplex virus ICP4 as an inhibitor of apoptosis
ARCH DEV CORP42 citations94
US6120773ASep 19, 2000
Recombinant herpes simplex viruses vaccines and methods
ARCH DEV CORP25 citations92
US6071692AJun 6, 2000
Herpes simplex virus as a vector
ARCH DEV CORP20 citations92
US5846707ADec 8, 1998
Herpes simplex virus as a vector
ARCH DEV CORP33 citations92
US5478727ADec 26, 1995
Methods and compositions for the preparation and use of a herpes protease
ARCH DEV CORP22 citations92
US6340673B1Jan 22, 2002
Method of treating tumorigenic disease
ARCH DEV CORP30 citations90
US6172047B1Jan 9, 2001
Method of screening candidate protective, potentiating, or inhibiting substances
ARCH DEV CORP37 citations90
US5834216ANov 10, 1998
Screening methods for the identification of inducers and inhibitors of programmed cell death (apoptosis)
ARCH DEV CORP30 citations90
US6383738B1May 7, 2002
Herpes simplex virus ORF P is a repressor of viral protein synthesis
ARCH DEV CORP18 citations89
US5641651AJun 24, 1997
Synthetic herpes simplex virus promoters
ARCH DEV CORP6 citations74
US6410704B1Jun 25, 2002
Methods and compositions for the preparation and use of a herpes protease
ARCH DEV CORP5 citations73
US6723511B2Apr 20, 2004
Herpes simplex virus ICP4 is an inhibitor of apoptosis
ARCH DEV CORP6 citations72
US6218103B1Apr 17, 2001
Herpes simplex virus US3 and ICP4 as inhibitors of apoptosis
ARCH DEV CORP10 citations72
US6210926B1Apr 3, 2001
Herpes simplex virus ICP4 is an inhibitor of apoptosis
ARCH DEV CORP8 citations72
US5846948ADec 8, 1998
Herpes simplex virus ORF P is a repressor of viral protein synthesis
ARCH DEV CORP9 citations70
US5334498AAug 2, 1994
Herpes simplex virus 1 UL13 gene product: methods and compositions
ARCH DEV CORP8 citations66
US5795713AAug 18, 1998
Methods for identifying inducers and inhibitors of programmed cell death
ARCH DEV CORP3 citations63
US5714153AFeb 3, 1998
Method of inducing antibody production against an infectious agent in a host
ARCH DEV CORP4 citations63
US8772261B2Jul 8, 2014
Treatment of tumors with genetically engineered herpes virus
ARCH DEV CORP1 citations51
UNIV CHICAGO
8 patentsUS6846670B2Jan 25, 2005
Genetically engineered herpes virus for the treatment of cardiovascular disease
UNIV CHICAGO32 citations92
US7892740B2Feb 22, 2011
Prognosis and therapy predictive markers and methods of use
UNIV CHICAGO20 citations86
US7744899B2Jun 29, 2010
Recombinant herpes simplex virus useful for treating neoplastic disease
UNIV CHICAGO17 citations82
US9669036B2Jun 6, 2017
Modulation of reactivation of a latent virus
UNIV CHICAGO10 citations77
US7550148B2Jun 23, 2009
Targeting of Herpes simplex virus to specific receptors
UNIV CHICAGO2 citations60
US7501126B2Mar 10, 2009
Targeting of herpes simplex virus to specific receptors
UNIV CHICAGO2 citations51
US9803006B2Oct 31, 2017
Targeting of herpes simplex virus to specific receptors
UNIV CHICAGO0 citations49
US10561708B2Feb 18, 2020
Anti-tumor therapy
UNIV CHICAGO0 citations48